Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer
Breast cancer patients diagnosed by pathology;
EOOG score is 0 or 1;
The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination);
Accept regular follow-up visits; ⑨ There is complete pathological data available.
Non breast cancer patients;
Received electroacupuncture treatment within 6 months prior to the start of the study;
Patients who experience intolerable toxic side effects during standard dose chemotherapy and terminate the chemotherapy cycle;
Prior to enrollment, there was a history of peripheral neuropathy;
Parallel
Electro-acupuncture
BehavioralA method of acupuncture that combines acupuncture with a certain frequency of electrical stimulation. Electrical stimulation is a mild level of stimulation intensity that is acceptable to the human body.
Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity Index （FACT/GOG-NTX）
This scale is mainly used to evaluate chemotherapy induced peripheral neuropathy (CIPN), especially the neurotoxic reactions in gynecological tumor treatment. Through this scale, it is possible to quantify the neurotoxic symptoms that patients experience after receiving chemotherapy, such as sensory abnormalities, motor dysfunction, etc., in order to better monitor and manage the patient's health status.
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire CIPN-20.
This scale is used to evaluate the impact of chemotherapy induced peripheral neuropathy (CIPN) on the quality of life of patients.
Click on the lead sponsor to view all of their trials.
